Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis

Infection and Immunity

Volumn 68, Issue 2, 2000, Pages 615-620

  Leib, Stephen L ^a   Leppert, David ^b   Clements, John ^c   Täuber, Martin G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GELATINASE B; ILOMASTAT; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BRAIN HOMOGENATE; BRAIN INJURY; CEREBROSPINAL FLUID; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG EFFECT; GENE EXPRESSION; HISTOPATHOLOGY; HOUSEKEEPING GENE; INFLAMMATION; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BRAIN; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MENINGITIS, PNEUMOCOCCAL; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033984374     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.2.615-620.2000     Document Type: Article

References (49)

1. Angstwurm, K., D. Freyer, U. Dirnagl, U. K. Hanisch, R. R. Schumann, K. M. Einhaupl, and J. R. Weber. 1998. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, hut augments experimental meningitis. Neuroscience 86:627-634.
2. Anthony, D. C., B. Ferguson, M. K. Matyzak, K. M. Miller, M. M. Esiri, and V. H. Perry. 1997. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23:406-415.
3. Anthony, D. C., K. M. Miller, S. Fearn, M. J. Townsend, G. Opdenakker, G. M. Wells, J. M. Clements, S. Chandler, A. J. Gearing, and V. H. Perry. 1998. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 87:62-72.
4. Arditi, M., E. O. Mason, Jr., J. S. Bradley, T. Q. Tan, W. J. Barson, G. E. Schutze, E. R. Wald, L. B. Givner, K. S. Kim, R. Yogev, and S. L. Kaplan. 1998. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102:1087-1097.
5. Azeh, I., M. Mader, A. Smirnov, W. Beuche, R. Nau, and F. Weber. 1998. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci. Lett. 256:127-30.
6. Chandler, S., J. Cossins, J. Lury, and G. Wells. 1996. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem. Biophys. Res. Commun. 228: 421-429.
7. Chandler, S., K. M. Miller, J. M. Clements, J. Lury, D. Corkill, D. C. Anthony, S. E. Adams, and A. J. Gearing. 1997. Matrix metalloproteinases. tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72:155-161.
8. Clements, J. M., J. A. Cossins, G. M. Wells, D. J. Corkill, K. Helfrich, L. M. Wood, R. Pigott, G. Stabler, G. A. Ward, A. J. Gearing, and K. M. Miller. 1997. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J. Neuroimmunol. 74:85-94.
9. Daoud, A. S., A. Batieha, M. Al-Sheyyab, F. Abuekteish, A. Obeidat, and T. Mahafza. 1999. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur. J. Pediatr. 158:230-233.
10. Deb, S., and P. E. Gottschall. 1996. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 66:1641-1647.
11. Dencoff, J. E., G. A. Rosenberg, and G. J. Harry. 1997. Trimethyltin induces gelatinase B and urokinase in rat brain. Neurosci Lett. 228:147-150.
12. Faustmann, P. M., D. Krause, R. Dux, and R. Dermietzel. 1995. Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol. (Berlin) 89:239-247.
13. Forderreuther, S., K. Tatsch, K. M. Einhaupl, and H. W. Pfister. 1992. Abnormalities of cerebral blood flow in the acute phase of bacterial meningitis in adults. J. Neurol. 239:431-436.
14. Galardy, R. E., M. E. Cassabonne, C. Giese, J. H. Gilbert, F. Lapierre, H. Lopez, M. E. Schaefer, R. Stack, M. Sullivan, B. Summers, et al. 1994. Low molecular weight inhibitors in corneal ulceration. Ann. N. Y. Acad. Sci. 732: 315-323.
15. Gearing, A. J., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, et al. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557.
16. Gijbels, K., R. E. Galardy, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Investig. 94:2177-2182.
17. Gottschall, P. E., and S. Deb. 1996. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3:69-75.
18. Grimwood, K., T. M. Nolan, L. Bond, V. A. Anderson, C. Catroppa, and E. H. Keir. 1996. Risk factors for adverse outcomes of bacterial meningitis. J. Paediatr. Child Health 32:457-462.
19. Hess, D. C., Y. Thompson, A. Sprinkle, J. Carroll, and J. Smith. 1996. E-selectin expression on human brain microvascular endothelial cells. Neurosci. Lett. 213:37-40.
20. Keenan, P. A., M. W. Jacobs, R. W. Solemani, and J. W. Newcomer. 1995. Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann. N. Y. Acad. Sci. 761:400-402.
21. Kieseier, B. C., R. Paul, U. Koedel, T. Seifert, J. M. Clements, A. J. Gearing, H. W. Pfister, and H. P. Hartung. 1999. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122:1579-1587.
22. Kim, Y. S., R. A. Sheldon, B. R. Elliott, Q. Liu, D. M. Ferriero, and M. G. Täuber. 1995. Brain injury in experimental neonatal meningitis due to group B streptococci. J. Neuropathol. Exp. Neurol. 54:531-539.
23. Kolb, S. A., F. Lahrtz, R. Paul, D. Leppert, D. Nadal, H. W. Pfister, and A. Fontana. 1998. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84:143-150.
24. Leib, S. L., Y. S. Kim, L. L. Chow, R. A. Sheldon, and M. G. Täuber. 1996. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Investig. 98:2632-2639.
25. Leib, S. L., Y. S. Kim, D. M. Ferriero, and M. G. Täuber. 1996. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J. Infect. Dis. 173:166-171.
26. Leib, S. L., D. Leppert, J. Clements, and M. G. Täuber. 1999. Role of matrix metalloproteinases in the pathogenesis of bacterial meningitis, p. 57. In Keystone Symposia: effectors of inflammation in the CNS. Keystone Symposia on Molecular and Cellular Biology, Taos, N. Mex.
27. Leppert, D., E. Waubant, R. Galardy, N. W. Bunnett, and S. L. Hauser. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:4379-4389.
28. McCracken, G. H. J., and X. Saez-Llorens. 1997. Contribution of cytokines to meningeal inflammation in bacterial meningitis, p. 107-123. In P. K. Peterson and J. S. Remington (ed.), In defense of the brain. Blackwell Science, Malden, Mass.
29. McIntyre, P. B., C. S. Berkey, S. M. King, U. B. Schaad, T. Kilpi, G. Y. Kanra, and C. M. Perez. 1997. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925-931.
30. Mollinedo, F., M. Nakajima, A. Llorens, E. Barbosa, S. Callejo, C. Gajate, and A. Fabra. 1997. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem. J. 327:917-923.
31. Mun-Bryce, S., and G. A. Rosenberg. 1998. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274: R1203-R1211.
32. Mustafa, M. M., O. Ramilo, K. D. Olsen, P. S. Franklin, E. J. Hansen, B. Beutler, and G. H. McCracken, Jr. 1989. Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J. Clin. Investig. 84:1253-1259.
33. Pagenstecher, A., A. K. Stalder, C. L. Kincaid, S. D. Shapiro, and I. L. Campbell. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152:729-741.
34. Parvathy, S., I. Hussain, E. H. Karran, A. J. Turner, and N. M. Hooper. 1998. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotcase inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 37:1680-1685.
35. Paul, R., S. Lorenzl, U. Koedel, B. Sporer, U. Vogel, M. Frosch, and H. W. Pfister. 1998. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44:592-600.
36. Perides, G., M. E. Charness, L. M. Tanner, O. Peter, N. Satz, A. C. Steere, and M. S. Klempner. 1998. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J. Infect. Dis. 177:401-408.
37. Perry, J. R., J. M. Bilbao, and T. Gray. 1992. Fatal basilar vasculopathy complicating bacterial meningitis. Stroke 23:1175-1178.
38. Pfister, H. W., G. D. Borasio, U. Dirnagl, M. Bauer, and K. M. Einhaupl. 1992. Cerebrovascular complications of bacterial meningitis in adults. Neurology 42:1497-1504.
39. Pikis, A., J. Kavaliotis, J. Tsikoulas, P. Andrianopoulos, D. Venzon, and S. Manios. 1996. Long-term sequelae of pneumococcal meningitis in children. Clin. Pediatr. 35:72-78.
40. Ramilo, O., X. Saez-Llorens, J. Mertsola, H. Jafari, K. D. Olsen, E. J. Hansen, M. Yashinaga, S. Ohkawara, H. Nariuchi, and G. H. McCracken, Jr. 1990. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J. Exp. Med. 172:497-507.
41. Romanic, A. M., R. F. White, A. J. Arleth, E. H. Ohlstein, and F. C. Barone. 1998. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020-1030.
42. Rosenberg, G. A., E. Y. Estrada, J. E. Dencoff, and W. G. Stetler-Stevenson. 1995. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 703:151-155.
43. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337:970-976.
44. Solorzano, C. C., R. Ksontini, J. H. Pruitt, T. Auffenberg, C. Tannahill, R. E. Galardy, G. P. Schultz, S. L. MacKay, E. M. Copeland III, and L. L. Moldawer. 1997. A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. Shock 7:427-431.
45. Täuber, M. G., Y. S. Kim, and S. L. Leib. 1997. Neuronal injury in meningitis, p. 124-143. In P. K. Peterson and J. S. Remington (ed.), In defense of the brain. Blackwell Science, Malden, Mass.
46. Tunkel, A. R., and W. M. Scheld. 1993. Pathogenesis and pathophysiology of bacterial meningitis. Clin. Microbiol. Rev. 6:118-136.
47. Wang, P., Z. F. Ba, R. E. Galardy, and I. H. Chaudry. 1996. Administration of a matrix metalloproteinase inhibitor after hemorrhage improves cardiovascular and hepatocellular function. Shock 6:377-382.
48. Yong, V. W., C. A. Krekoski, P. A. Forsyth, R. Bell, and D. R. Edwards. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21: 75-80.
49. Zysk, G., W. Bruck, J. Gerber, Y. Bruck, H. W. Prange, and R. Nau. 1996. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 55:722-728.